z-logo
Premium
Plasma‐free vs deconjugated metanephrines for diagnosis of phaeochromocytoma
Author(s) -
Pamporaki Christina,
Därr Roland,
Bursztyn Michael,
Glöckner Stephan,
Bornstein Stefan R.,
Lenders Jacques W. M.,
Pacak Karel,
Krinner Axel,
Eisenhofer Graeme
Publication year - 2013
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12191
Subject(s) - metanephrine , normetanephrine , metanephrines , medicine , pheochromocytoma , population , endocrinology , urology , environmental health
Summary Background The diagnosis of phaeochromocytoma is commonly performed by the measurements of plasma‐free normetanephrine and metanephrine. Plasma‐deconjugated normetanephrine and metanephrine have been proposed as alternative, equivalent, but easier to measure biomarkers. Objective The aim of this study was to compare the diagnostic performance of plasma‐free vs deconjugated normetanephrine and metanephrine in patients tested for phaeochromocytoma. Methods The study population included a reference group of 262 normotensive and hypertensive volunteers, 198 patients with phaeochromocytoma and 528 patients initially suspected of having the tumour, but with negative investigations after at least 2 years of follow‐up. Measurements were performed using liquid chromatography with electrochemical detection. Results Plasma concentrations of free normetanephrine were 17‐fold higher in patients with phaeochromocytoma than in the reference population, a 72% larger ( P  < 0·001) difference than that for the 10‐fold higher levels of plasma‐deconjugated normetanephrine. In contrast, relative increases in plasma concentrations of free and deconjugated metanephrine were similar. Using upper cut‐offs established in the reference population, measurements of plasma‐free metabolites provided superior diagnostic performance than deconjugated metabolites according to measures of both sensitivity (97% vs 92%, P  = 0·002) and specificity (93% vs 89%, P  = 0·012). The area under the receiver operating characteristic curve for the free metabolites was larger than that for the deconjugated metabolites (0·986 vs 0·965, P  < 0·001). Conclusion Measurements of plasma‐free normetanephrine and metanephrine are superior to the deconjugated metabolites for diagnosis of phaeochromocytoma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here